Alexandra Seminova

Bloomberg News equities reporter providing on-the-ground reporting and analysis on company-specific moves, including coverage of Novo Nordisk, Amazon, and Tesla in this episode.

Best podcasts with Alexandra Seminova

Ranked by the Snipd community

4 snips

Nov 24, 2025 • 5min

Novo Nordisk's Ozempic Pill Fails to Slow Alzheimer's, Amazon Rises, Tesla Jumps

Alexandra Seminova, an equities reporter from Bloomberg News, dives into major market moves impacting investors. She discusses the setback facing Novo Nordisk after Ozempic's Alzheimer's trial failed, causing a stock decline. Meanwhile, Amazon is making waves with a bold $50 billion investment to enhance AI and computing services for the U.S. government. Alexandra also highlights Tesla's stock surge following Elon Musk's announcement about their AI chip developments, showcasing the firm's innovative edge.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app